Verywell Health on MSN1 年
What Are Myeloproliferative Disorders?
Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...
Healthline5 天
Myeloproliferative Disorders: Types and Treatments
Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers involving the uncontrolled replication of cells derived from myeloid stem cells.
Pharmaceutical Technology8 天
Veliparib ER by AbbVie for Myeloproliferative Disorders: Likelihood of Approval
Veliparib ER is under clinical development by AbbVie and currently in Phase II for Myeloproliferative Disorders.
The American Journal of Managed Care6 天
Personalizing MPN Disease Management and Monitoring
The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and ...
Cure Today5 天
A Commitment to New Therapies for MPN Despite Scientific Challenges
One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment ...
Pharmaceutical Technology8 天
HMPL-306 by Hutchison MediPharma for Myeloproliferative Disorders: Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Myeloproliferative Disorders.
The American Journal of Managed Care7 天
The Challenge of Managing Both Disease Symptoms and Drug Side Effects in Myelofibrosis
There’s a balance required to manage both the symptoms of myelofibrosis through treatment and the side effects caused by the ...
Medscape4 年
Treatment Options for Essential Thrombocythemia and Polycythemia Vera
Polycythemia vera and essential thrombocythemia are the most common chronic myeloproliferative neoplasms ... are pushing therapeutic goals from disease control only to cure.